. [82] to evaluate the efficacy, safety and tolerability of Cannabidiol being an adjunct therapy together with anti-epileptic drugs about the patients suffering from tuberous sclerosis elaborate whose commonest neurological symptom is epilepsy. During this scientific trial study, right after treatment with Cannabidiol, responder amount in the suffe